NAD+ 20mg — Vial Spec, Reconstitution Math & COA
The NAD+ 20mg research vial provides a highly purified, lyophilized formulation of Nicotinamide Adenine Dinucleotide designed specifically for low-volume in vitro assays, enzymatic titrations, and cell culture studies. This specialized unit size allows laboratory researchers to minimize solvent waste while maintaining precise concentration control in bioenergetic experimental protocols.
Quick answer
The NAD+ 20mg research vial provides a highly purified, lyophilized formulation of Nicotinamide Adenine Dinucleotide designed specifically for low-volume in vitro assays, enzymatic titrations, and cell culture studies. This specialized unit size allows laboratory researchers to minimize solvent waste while maintaining precise concentration control in bioenergetic experimental protocols.
Key takeaways
- Nicotinamide Adenine Dinucleotide ([NAD+](/research-peptides/nad-plus)) is an essential coenzyme present in all living cells, serving as a critical electron carrier in cellular respiration and a necessary substrate for enzymes involved in genomic stability, gene expression, and metabolic regulation.
- While the 20mg specification represents an ideal unit size for specialized low-volume screening, PX1 Research maintains a dynamic catalog of analytical-grade coenzymes and peptides tailored to scaled laboratory requirements.
- Accurate reconstitution mathematics are paramount when preparing working stock solutions from a 20mg lyophilized [NAD+](/research-peptides/nad-plus) vial.
- To preserve the bioactivity and structural stability of [NAD+](/research-peptides/nad-plus), reconstitution must be performed under strict aseptic laboratory conditions using calibrated micro-pipettes and sterile reagents.
Overview of the 20mg NAD+ Research Mass Spec
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells, serving as a critical electron carrier in cellular respiration and a necessary substrate for enzymes involved in genomic stability, gene expression, and metabolic regulation. A 20mg vial specification of NAD+ contains strictly 20 milligrams of active coenzyme in a stabilized, lyophilized cake format, processed under controlled cleanroom conditions to prevent ambient moisture absorption and oxidation.
Principal investigators and research technicians typically select the 20mg vial format when executing targeted assay series that require fresh, working-strength solutions without the risk of degradation associated with repeated freeze-thaw cycles of larger bulk quantities. Because aqueous NAD+ hydrolyzes over time, maintaining a modest, single-session aliquot mass ensures consistent enzymatic activity across microplate assays, Western blot controls, and cell viability assays.
Every batch of research-grade NAD+ distributed by PX1 Research undergoes rigorous testing protocols to verify absolute mass, structural integrity, and chemical purity. When establishing experimental baselines, researchers relying on precise molar concentrations benefit from the standardized fill volume and low variance of this dedicated 20mg mass specification.
PX1 Research Catalog Sizing and Availability Notice
While the 20mg specification represents an ideal unit size for specialized low-volume screening, PX1 Research maintains a dynamic catalog of analytical-grade coenzymes and peptides tailored to scaled laboratory requirements. Researchers evaluating our primary catalog can review the full range of available formats by visiting our dedicated NAD+ product page, where current lot availability, mass configurations, and bulk option parameters are regularly updated.
In addition to specialized coenzyme formulations, PX1 Research provides a broad spectrum of pure reference materials for comparative metabolic and cellular bioenergetic studies. Investigators seeking to align their experimental designs across multiple target classes can browse our complete inventory through the all peptides directory.
If a specific mass variant such as the 20mg vial is currently undergoing re-lotting or custom synthesis, researchers can request analytical custom fills or explore our higher-capacity standard sizes (such as 100mg or 500mg mass specifications) to maintain continuous assay throughput without altering reconstituted molarity ratios.
Reconstitution Mathematics for 20mg NAD+ Vials
Accurate reconstitution mathematics are paramount when preparing working stock solutions from a 20mg lyophilized NAD+ vial. The final concentration of the coenzyme solution is directly dependent on the volume of sterile reconstituting diluent added to the vial. The basic formula governing concentration calculation is: Concentration (c) = Mass (m) / Volume (V).
When introducing 1.0 mL of reconstituting liquid (such as sterile bacteriostatic water or standard phosphate-buffered saline) into a 20mg vial, the resulting stock concentration is precisely 20.0 mg/mL (or 20.0 µg/µL). Converting this mass concentration to millimolar (mM) concentration based on the molecular weight of NAD+ (663.43 g/mol) yields a solution of approximately 30.14 mM. This high-density stock is ideal for minimal-volume pipetting into large assay plates.
For assays requiring lower working stock concentrations to reduce volumetric pipetting errors, adding 2.0 mL of diluent yields a final concentration of 10.0 mg/mL (10.0 µg/µL, or approximately 15.07 mM). Adding 3.0 mL of diluent produces a concentration of 6.67 mg/mL (6.67 µg/µL, or approximately 10.05 mM). Researchers can quickly model custom volumetric ratios and final working molarities using our interactive online reconstitution calculator.
Standardized Laboratory Reconstitution Protocol
To preserve the bioactivity and structural stability of NAD+, reconstitution must be performed under strict aseptic laboratory conditions using calibrated micro-pipettes and sterile reagents. Prior to reconstituting, the lyophilized 20mg vial should be allowed to equilibrate to room temperature inside a laminar flow hood to prevent condensation from forming on the dry powder cake upon opening.
Sanitize the rubber septum of the vial using a 70% isopropyl alcohol swab and allow it to air-dry completely. Using a sterile syringe, draw the predetermined volume of diluent (e.g., 1.0 mL, 2.0 mL, or 3.0 mL of sterile water for injection or PBS) and gently insert the needle through the center of the rubber stopper at a 45-degree angle. Direct the stream of fluid down the glass interior wall of the vial rather than shooting it directly onto the lyophilized cake.
Once the diluent has been completely transferred, slowly invert or gently swirl the vial until the solid cake is completely dissolved. Avoid vigorous shaking, vortexing, or excessive agitation, which can induce shear stress, foam formation, and structural denaturation of fragile biochemical compounds. The clear, colorless solution is then ready for immediate experimental deployment or immediate sub-aliquoting.
Aliquot Strategy and Hydrolytic Stability Management
In aqueous solution, the dinucleotide structure of NAD+ is sensitive to enzymatic degradation, temperature fluctuations, and nucleophilic attack, leading to progressive hydrolysis into nicotinamide and ADP-ribose over extended storage periods. To maintain lot consistency across longitudinal studies, researchers must establish a rigorous aliquot strategy immediately following reconstitution.
Working stock solutions generated from the 20mg vial should be divided into single-use, polypropylene micro-centrifuge tubes (e.g., 50 µL to 100 µL per tube) using sterile techniques inside a biosafety cabinet. Utilizing single-use aliquots eliminates the need for repeated freeze-thaw cycles, which are known to significantly degrade coenzyme potency and alter baseline spectrophotometric readings.
Aliquots intended for short-term use (less than 48 hours) may be kept sealed at 2°C to 8°C protected from light. Aliquots required for long-term study protocols should be flash-frozen using liquid nitrogen or a dry ice/ethanol bath and stored in a specialized ultra-low temperature freezer at -80°C. Stored under these conditions, degradation rates remain below analytical detection thresholds for several months.
Lot-Matched COA and Quality Control Standards
Every production lot of NAD+ supplied by PX1 Research undergoes rigorous independent verification to guarantee high analytical purity and absolute identity. Quality assurance protocols require dual-spectrum testing combining High-Performance Liquid Chromatography (HPLC) to measure chemical purity and Mass Spectrometry (MS) to verify precise molecular weight.
Researchers can inspect and download the official analytical documentation for their specific batch via our dedicated certificate of analysis hub. Each lot-matched COA provides raw chromatograms, UV absorption ratios, mass spec spectra, and specific assay parameters verifying that the compound meets our strict analytical standard of ≥98.0% purity.
Furthermore, because cellular bioenergetic models and cell culture assays are exceptionally sensitive to bacterial contaminants, PX1 Research subjects every batch to rigorous chromogenic LAL endotoxin testing. Endotoxin levels are verified to remain below stringent laboratory thresholds (<0.01 EU/mg), ensuring that observed cellular responses are driven entirely by the experimental variable rather than pyrogenic artifacts.
Comparative Analysis: 20mg vs. High-Capacity Vials
Selecting the correct vial size depends largely on experimental scale, assay frequency, and budget optimization. The 20mg vial format serves as a precise, low-risk option for pilot studies, method validation, or low-throughput enzymatic assays where working solutions must be prepared fresh for every run to avoid storage-induced variance.
Conversely, high-throughput screening applications or large-scale comparative research models may benefit from larger mass specifications. Higher-capacity formats reduce overall packaging overhead and streamline high-volume assay preparation. However, utilizing a single 100mg or 500mg vial requires immediate large-scale aliquoting and substantial sub-zero storage capacity to mitigate the hydrolytic risks described above.
When designing multi-compound experimental panels alongside related metabolic research molecules—such as MOTS-c for mitochondrial gene expression studies or SS-31 for cardiolipin-targeted membrane research—researchers often pair 20mg NAD+ vials with complementary peptides to establish balanced molar ratios across parallel cell culture treatments.
Preclinical Mechanisms and In Vitro Research Applications
In preclinical and in vitro research environments, NAD+ functions as an essential oxidizing cofactor in glycolysis, the Krebs cycle, and beta-oxidation. Beyond its central metabolic role, NAD+ acts as a required co-substrate for key regulatory enzymes, including poly(ADP-ribose) polymerases (PARPs), sirtuins (SIRT1–SIRT7), and cyclic ADP-ribose synthases (CD38/CD157).
In vitro data indicate that modulating intracellular or extracellular NAD+ pools alters Sirtuin-mediated deacetylase activity, directly influencing mitochondrial biogenesis, oxidative stress response pathways, and chromatin remodeling. Preclinical cell culture models frequently utilize exogenous NAD+ supplementation in culture media to evaluate its impact on cellular senescence, DNA repair kinetics, and bioenergetic rescue under induced metabolic stress.
Researchers investigating broader cellular longevity and bioenergetic control mechanisms can consult our central research library hub to access detailed documentation regarding receptor dynamics, pathway interactions, and recent publications involving metabolic coenzymes and regulatory peptides.
Storage Parameters and Physical Handling Precautions
To ensure maximum shelf stability, unopened lyophilized 20mg NAD+ vials must be stored in a dark, dry environment at temperatures between -20°C and -80°C. Exposure to direct sunlight, high ambient humidity, or ambient room temperatures for extended periods accelerates moisture absorption and premature degradation of the lyophilized matrix.
Vials are shipped with protective seals to prevent ambient contamination. When receiving shipment from PX1 Research's CA or AZ logistics facilities, research staff should inspect the package indicators, verify outer seal integrity, and immediately transfer the vials to designated freezer storage. Never attempt to heat or microwave lyophilized vials to speed up temperature equilibration.
When handling dry powder or concentrated liquid stocks, appropriate personal protective equipment (PPE)—including nitrile gloves, safety glasses, and laboratory coats—must be worn at all times. All waste disposal and container neutralization should follow local biohazard and chemical disposal safety standards.
Ordering, Shipping, and Laboratory Account Support
PX1 Research operates dedicated manufacturing and distribution operations within the USA, adhering strictly to GMP-compliant processes and ISO 17025 accredited laboratory testing standards. Orders placed Monday through Friday before our daily cutoff time are dispatched same-day from our strategically located West Coast distribution hubs in California and Arizona.
Academic institutions, biotechnology firms, and contract research organizations requiring sustained supply agreements can establish streamlined purchasing workflows via our wholesale accounts portal. Bulk laboratory accounts benefit from prioritized lot reservations, customized analytical reporting, and dedicated technical account management.
All materials supplied by PX1 Research are sold strictly as research chemical compounds intended exclusively for laboratory, in vitro, and preclinical research applications. They are strictly not for human, clinical, diagnostic, or veterinary use.
Frequently Asked Questions
What exact mass of NAD+ is contained in the 20mg research vial?
Each 20mg vial contains strictly 20 milligrams of analytical-grade, lyophilized Nicotinamide Adenine Dinucleotide (NAD+) coenzyme, verified by high-performance liquid chromatography.
What is the concentration when 2mL of reconstituent is added to a 20mg NAD+ vial?
Adding 2.0 mL of reconstituting diluent to a 20mg vial yields a stock concentration of 10.0 mg/mL (or 10.0 µg/µL), corresponding to a molarity of approximately 15.07 mM based on a molecular weight of 663.43 g/mol.
Why is endotoxin testing necessary for NAD+ research vials?
Endotoxin testing ensures the absence of bacterial lipopolysaccharides (LPS), which can trigger non-specific immune signaling or cellular toxicity in sensitive cell culture models and obscure experimental outcomes.
How should reconstituted NAD+ solutions be stored to prevent hydrolysis?
Reconstituted NAD+ solutions should be sub-aliquoted into single-use micro-centrifuge tubes immediately and stored at -80°C to minimize hydrolytic degradation and prevent repeated freeze-thaw cycles.
Does PX1 Research provide analytical documentation for each lot?
Yes. Every lot is accompanied by a downloadable Certificate of Analysis (COA) accessible on our website, detailing HPLC mass purity, Mass Spectrometry structural confirmation, and endotoxin assay results.
Is the 20mg NAD+ vial format intended for human therapeutic use?
No. All products supplied by PX1 Research are strictly for laboratory research, in vitro assays, and preclinical animal models. They are never for human, clinical, diagnostic, or veterinary use.
What alternative vial sizes are available if 20mg is insufficient for my assay series?
PX1 Research offers multiple mass configurations depending on catalog availability, including 100mg and 500mg formats for higher-throughput screening workflows. Check our catalog or contact support for current sizes.
Where are PX1 Research NAD+ products manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based GMP-compliant facilities and shipped directly from our primary distribution centers located in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.